Suspension of trading
Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.48B 5.05B 4.66B 8.78B 603B 8.97B 60.4B 23.76B 296B 23.53B 23.02B 1,017B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.32B 4.91B 4.53B 8.53B 587B 8.72B 58.7B 23.09B 287B 22.87B 22.37B 989B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 1 month | +1.20% | ||
| 3 months | +2.12% | ||
| 6 months | +82.43% | ||
| Current year | +61.94% |
| 1 month | 39.98 |  | 40.56 |
| Current year | 21.5 | | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 2024-09-30 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 2023-02-28 |
David Chao
ADM | Chief Administrative Officer | 58 | 2021-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2026-06-23 | |
Kristina Wright
BRD | Director/Board Member | - | 2026-06-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/24/26 | Issuer sale | Director | -392,474 | 0.2537% | ||
| 6/24/26 | Medicxi Ventures (Jersey) Ltd.
| Issuer sale | Company | -19,963,157 | 12.9020% | |
| 6/24/26 | Issuer sale | Head of Human Resources | -486,345 | 0.3143% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +158.13% | +426.66% | 6.27B | |
| -1.29% | -3.11% | -0.35% | +3.09% | 49.18B | |
| +3.90% | -0.39% | +386.06% | +593.85% | 39.58B | |
| -1.70% | +4.46% | +5.93% | +60.25% | 34.69B | |
| -2.01% | -0.76% | +28.41% | -8.01% | 34.42B | |
| +0.06% | +0.34% | +2.38% | +34.38% | 27.11B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +72.42% | +115.55% | 15.36B | |
| +1.12% | +1.91% | +14.54% | +19.16% | 14.05B | |
| 0.00% | +1.36% | +18.43% | -30.79% | 13.02B | |
| Average | +0.13% | +0.21% | +76.22% | +134.90% | 24.99B | |
| Weighted average by Cap. | -0.03% | -0.13% | +81.55% | +131.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.11 12.1 11.15 21.02 1.44K 21.48 144.58 56.87 707.47 56.33 55.1 2.44K |
| Net income | -236M -206M -190M -175M -330M -22.7B -338M -2.27B -894M -11.12B -885M -866M -38.28B | -198M -173M -159M -147M -277M -19.02B -283M -1.9B -749M -9.32B -742M -726M -32.07B |
| Net Debt | -364M -318M -294M -271M -510M -35.09B -522M -3.51B -1.38B -17.18B -1.37B -1.34B -59.16B | -176M -154M -142M -131M -247M -16.97B -252M -1.7B -668M -8.31B -662M -647M -28.61B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
